Skip to main content
. 2021 Feb 21;41:101905. doi: 10.1016/j.redox.2021.101905

Fig. 3.

Fig. 3

Effects of N3-AZA on GAPDH and GSTP1 protein levels, GAPDH localization and their enzymatic activity. (A) Lysates prepared from N3-AZA (or 0.02% DMSO) treated normoxic and hypoxic FaDu cells were processed for western blotting. N3-AZA treatment did not alter GAPDH and GSTP1 protein levels regardless of O2 conditions. Representative immunoblots and quantitation [mean ± S.E.M.] from three independent experiments are displayed. (B) Cells treated with N3-AZA (or 0.02% DMSO) under normoxia and hypoxia were processed for immunocytochemistry to monitor GAPDH localization; no change in cellular localization of GAPDH was observed in response to N3-AZA treatment. The micrographs are representative of at least three independent experiments; scale bar = 20 μm. (C and D) FaDu cells treated with N3-AZA (or 0.02% DMSO) under normoxia and hypoxia were processed for GAPDH activity assay (C) or GST activity assay (D); the enzymatic activities of GAPDH and GST were significantly reduced only in N3-AZA treated hypoxic cells. Data represent mean ± S.E.M. from three independent experiments.